Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Letter to the Shareholders of Patriot Scientific Corporation from President/CEO
Reply New Message
Prev Message Back To Forum Threaded View Next Message

"At recent share prices, this initiative gives us $20-25 million in additional share value leverage with which to negotiate."

I asked Investor Relations two times, if these 100mio additional shares mean, that the company is not expecting the same value coming from the MMP licenses, but didn't receive an answer so far.

I would have preferred, if RG had said "this initiative gives us $100-250 million in additional share value at prices we expect for the next months"...lol

GLTA



3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply